Clinical Trial Update: Efficacy and Safety of Plasma Exchange With Albumin in Patients With Amyotrophic Lateral Sclerosis [Phase 2]

View source ↗

Summary

Phase 2 trial investigating plasma exchange with albumin for amyotrophic lateral sclerosis has been completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• plasma exchange with albumin (plasma exchange with albumin)

Snippet

Sponsor: Instituto Grifols, S.A. | Conditions: Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED | Results posted: 2020-06-16